The Use of Biomarkers for the Evaluation and Treatment of Patients with Acute Coronary Syndromes

Amy K. Saenger, Allan S. Jaffe

Research output: Contribution to journalReview article

20 Scopus citations

Abstract

The advent of inexpensive, highly accurate, and predictive markers of myocardial injury, inflammation, and hemodynamic stability has revolutionized the evaluation and treatment of patients who have acute coronary syndromes (ACSs). These blood biomarkers require small sample volumes, can be run expeditiously, and provide important information concerning the diagnosis, risk stratification, and treatment of these patients. To understand the use of these markers, one must have some knowledge about what elevations in these markers imply, how they have to be collected and measured to provide reliable information, when to suspect analytic confounds, and what the key values are that impart the diagnostic, prognostic, and therapeutic information. This article discusses these issues, emphasizing what clinicians must know for optimal test use, and then addresses the practical use of these markers in patients who have ACS.

Original languageEnglish (US)
Pages (from-to)657-681
Number of pages25
JournalMedical Clinics of North America
Volume91
Issue number4
DOIs
StatePublished - Jul 1 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The Use of Biomarkers for the Evaluation and Treatment of Patients with Acute Coronary Syndromes'. Together they form a unique fingerprint.

  • Cite this